EVALUATING LACTOFERRIN AND CALPROTECTIN AS MARKERS OF INTESTINAL INFLAMMATION INCHRONIC PANCREATITIS
ABSTRACT Background: The treatment of chronic pancreatitis does not consistently solve intestinal abnormalities, and despite the implementation of various therapeutic measures, patients often continue to experience persistent diarrhea. Therefore, it is imperative to recognize that diarrhea may stem...
Main Authors: | Claudia Teresa CARVENTE, Maria Lúcia Cardoso Gomes FERRAZ, Carlos Fischer de TOLEDO |
---|---|
Format: | Article |
Language: | English |
Published: |
Instituto Brasileiro de Estudos e Pesquisas de Gastroenterologia (IBEPEGE)
2024-03-01
|
Series: | Arquivos de Gastroenterologia |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-28032024000100206&lng=en&tlng=en |
Similar Items
-
Fecal calprotectin in the differential diagnosis of acute intestinal infections
by: E. D. Vlkova, et al.
Published: (2018-07-01) -
Prevalence of exocrine pancreatic insufficiency at 12 months after acute pancreatitis: a prospective, multicentre, longitudinal cohort studyResearch in context
by: Anna Evans Phillips, et al.
Published: (2024-09-01) -
Comparative analysis of the intestinal microbiota in patients with exocrine pancreatic insufficiency of various severity
by: Igor V. Maev, et al.
Published: (2023-03-01) -
Pancreatic enzyme replacement therapy in subjects with exocrine pancreatic insufficiency and diabetes mellitus: a real-life, case–control study
by: Laure Alexandre-Heymann, et al.
Published: (2024-02-01) -
Fecal calprotectin, lactoferrin and morbidity associated with immature digestive tract in preterm infants
by: D.S. Dobryk, et al.
Published: (2022-11-01)